References
- 1. S. Abbas, M. Hussain, S. Ali, M. Parvez, A. Raza, A. Haider and J. Iqbal, Structural, enzyme inhibition, antibacterial and DNA protection studies of organotin(IV) derivatives of thiophene-2- carboxylic acid, J. Organometallic Chem. 724 (2013) 255-261; DOI: 10.1016/j.jorganchem.2012.11.033.
- 2. A. M. Asiri and S. A. Khan, Synthesis and antibacterial activities of a bis-chalcone derived from thiophene and its bis-cyclized products, Molecules 16 (2011) 523-531; DOI: 10.3390/molecules160 10523.
- 3. A. M. Khalil, M. A. Berghot and M. A. Gouda, Synthesis and antibacterial activity of some new thiazole and thiophene derivatives, Eur. J. Med. Chem. 44 (2009) 4434-4440; DOI: 10.1016/j.ejmech. 2009.06.002.
- 4. S. Deka, S. Mohan, J. Saravanan, M. Kakati, A. Talukdar, B. J. Sahariah, B. K. Dey and R. K. Sarma, Syntheses, characterization and in-vitro anti-Inflammatory activity of some novel thiophenes, Maced. J. Med. Sci. 5 (2012) 159-163; DOI: org/10.3889/MJMS.1957-5773.2012.0225.
- 5. R. A. Forsch, J. E. Wright and A. Rosowsky, Synthesis and in vitro antitumor activity of thiophene analogues of 5-chloro-5,8-dideazafolic acid and 2-methyl-2-desamino-5-chloro-5,8-dideazafolic acid, Bioorg. Med. Chem. 10 (2002) 2067-2076; DOI: org/10.1016/S0968-0896(02)00018-4.
- 6. H. A. Saad, M. M. Youssef and M. A. Mosselhi, Microwave assisted synthesis of some new fused 1,2,4-triazines bearing thiophene moieties with expected pharmacological activity, Molecules, 16 (2011) 4937-4957; DOI: 10.3390/molecules16064937.
- 7. A. E. Rashad, A. H. Shamroukh, R. E. Abdel-Megeid, A. Mostafa, R. El-Shesheny, A. Kandeil, M. A. Ali and K. Banert, Synthesis and screening of some novel fused thiophene and thienopyrimidine derivatives for anti-avian influenza virus (H5N1) activity, Eur. J. Med. Chem. 45 (2010) 5251-5257; DOI: 10.1016/j.ejmech.2010.08.044.
- 8. M. M. Ghorab, F. A. Ragab and M. M. Hamed, Synthesis and docking studies of some novel quinoline derivatives bearing a sulfonamide moiety as possible anticancer agents, Arzneimittelforschung. Drug Res. 60 (2010) 141-148; DOI: 10.1055/s-0031-1296263.
- 9. M. M. Ghorab, F. A. Ragab, H. I. Heiba and R. M. El-Hazek, Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety, Eur. J. Med. Chem. 46 (2011) 5120-5126; DOI: 10.1016/j.ejmech.2011.08.026.
- 10. M. M. Ghorab, F. A. Ragab and M. M. Hamed, Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety, Eur. J. Med. Chem. 44 (2009) 4211-4217; DOI: 10.1016/j.ejmech.2009.05.017.
- 11. J. T. Arcari, J.S. Beebe, M. A. Berliner, V. Bernardo, M. Boehm, G. V. Borzillo, T. Clark, B. D. Cohen, R. D. Connell, H. N. Frost, D. A. Gordon, W. M. Hungerford, S. M. Kakar, A. Kanter, N. F. Keene, E. A. Knauth, S. D. LaGreca, Y. Lu, L. Martinez-Alsina and M. A. Marx, Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors, Bioorg. Med. Chem. Lett. 23 (2013) 3059-3063; DOI: 10.1016/j.bmcl.2013.03.012.
- 12. K. S. Abou-Melha, Octahedral Co(II) and Ni(II) complexes of schiff bases, semicarbazone and thiosemicarbazone, synthesis, biological, spectral, and thermal studies, J. Coordination Chem. 61 (2008) 2053-2067; DOI: 10.1080/00958970701862167.
- 13. S. S. Mohamed, S. A. Mohamed, E. S. Shalfoh and O. Fhid, Microwave assisted one-pot synthesis and screening of some schiff’s bases of sulfanilamide, J. Chem. Pharmaceutical. Res. 4 (2012) 2512-2516; DOI: 5-2012/JCPR-2012-4-5-2512-2516.
- 14. G. D. Simone and C. T. Supuran, Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target, Biochim. Biophys. Acta 1804 (2010) 404-409; DOI: 10.1016/j. bbapap.2009.07.027.
- 15. S. M. Marques, E. A. Enyedy, C. T. Supuran, N. I. Krupenko, S. A. Krupenko and M. A. Santos, Pteridine-sulfonamide conjugates as dual inhibitors of carbonic anhydrases and dihydrofolate reductase with potential antitumor activity, Bioorg. Med. Chem. 18 (2010) 5081-5089; DOI: 10.1016/j. bmc.2010.05.072.
- 16. H. M. Said, C. T. Supuran, C. Hageman, A. Staab, B. Polat, A. Katzer, A. Scozzafava, J. Anacker, M. Flentje and D. Vordermark, Modulation of carbonic anhydrase 9 (CA9) in human brain cancer, Curr. Pharm. Des. 16 (2010) 3288-3299; DOI: 10.2174/138161210793429788.
- 17. W. R. Chegwidden, S. J. Dodgson and I. M. Spencer, The roles of carbonic anhydrase in metabolism, cell growth and cancer in animals, EXS 90 (2000) 343-363; DOI: 10.1016/pubmed.11268523.
- 18. B. E. Maryanoff and M. J. Costan, Inhibitors of proteases and amide hydrolases that employ an α-ketoheterocycle as a key enabling functionality, Bioorg. Med. Chem. 16 (2008) 1562-1595; DOI: 10.1016/j.bmc.2007.11.015.
- 19. S. Bondock, W. Fadaly and M. A. Metwally, Enaminonitrile in heterocyclic synthesis: Synthesis and antimicrobial evaluation of some new pyrazole, isoxazole and pyrimidine derivatives incorporating a benzothiazole moiety, Eur. J. Med. Chem. 44 (2009) 4813-4818; DOI: 10.1016/j.ejmech.2009.07.024.
- 20. P. J. Bindu, K. M. Mahadevan and T. R. Ravikumar Naik, An efficient one-pot synthesis and photoinduced DNA cleavage studies of 2-chloro-3-(5-aryl-4,5-dihydroisoxazol-3-yl)quinolines, Bioorg. Med. Chem. Lett. 22 (2012) 6095-6098; DOI: 10.1016/j.bmcl.2012.08.034.
- 21. M. S. Al-Dosari, M. M. Ghorab, M. S. Alsaid, Y. M. Nissan and A. B. Ahmed, Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety, Eur. J. Med. Chem. 69 (2013) 373-383; DOI: 10.1016/j.ejmech.2013.08.048
- 22. M. Sankaran, C. Kumarasamy, U. Chokkalingam and P. S. Mohan, Synthesis, antioxidant and toxicological study of novel pyrimidoquinoline derivatives from 4-hydroxy-3-acyl quinolin-2- one, Bioorg. Med. Chem. Lett. 20 (2010) 7147-7151; DOI: 10.1016/j.bmcl.2010.09.018.
- 23. A.R. Ellanki, A. Islam, V. S. Rama, R. P. Pulipati, D. Rambabu, G. R. Krishna, M. C. Reddy, K. Mukkanti, G. R. Vanaja, A. M. Kalle, S. K. Kumar and P. Manojit, Solvent effect on copper-catalyzed azide-alkyne cycloaddition (CuAAC): Synthesis of novel triazolyl substituted quinolines as potential anticancer agents, Bioorg. Med. Chem. Lett. 22 (2012) 3455-3459; DOI: 10.1016/j.bmcl.2012. 03.091.
- 24. L. Wang, M. Switalska, Z. Mei, W. Lu, Y. Takahara, X. Feng, I. E. El-Sayed, J. Wietrzyk and T. Inokuchi, Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners, Bioorg. Med. Chem. 20 (2012) 4820-4829; DOI: 10.1016/j.bmc.2012.05.054.
- 25. L. Fu, W. Lin, P. Xu, Y. Xi, M. Wang and D. Shi, Novel and efficient synthesis of substituted quinoline-1-oxides and the complex compounds SnL2Cl2 (L=2-aminoquinoline-1-oxides) with the aid of stannous chloride, Tetrahedron. 68 (2012) 7782-7786; DOI: 10.1016/j.tet.2012.07.049.
- 26. T. Yamaguchi, S. Watanabe, Y. Matsumura, Y. Tokuoka and A. Yokoyama, Oxovanadium com complexes with quinoline and pyridinone ligands: Syntheses of the complexes and effect of alkyl chains on their apoptosis-inducing activity in leukemia cells, Bioorg. Med. Chem. 20 (2012) 3058-3064; DOI: 10.1016/j.bmc.2012.02.063.
- 27. S. A. F. Rostom, Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores and some derived thiazole ring systems, Bioorg. Med. Chem. 14 (2006) 6475-6485; DOI: 10.1016/j.bmc.2006.06.020.
- 28. J. E. Payne, C. Bonnefous, C. A. Hassig, K. T. Symons, X. Guo, P. M. Nguyen, T. Annable, P. L. Wash, T. Z. Hoffman, T. S. Rao, A. K. Shiau, J. W. Malecha, S. A. Noble, J. H. Hager and N. D. Smith, Identification of KD5170: a novel mercaptoketone-based histone deacetylase inhibitor, Bioorg. Med. Chem. Lett. 18 (2008) 6093-6096; DOI: 10.1016/j.bmcl.2008.10.029.
- 29. M. M. Ghorab, F. A. Ragab, H. I. Heiba, R. K. Arafa and E. M. El-Hossary, Docking study, in vitro anticancer screening and radiosensitizing evaluation of some new fluorine-containing quinoline and pyrimidoquinoline derivatives bearing a sulfonamide moiety, Med. Chem. Res. 20 (2011) 388-400; DOI: 10.1007/s00044-010-9332-3.
- 30. M. S. Alsaid, M. S. Bashandy, S. I. Alqasomi and M. M. Ghorab, Anti-breast cancer activity of some novel 1,2- dihydropyridine, thiophene and thiazole derivatives, Eur. J. Med. Chem. 46 (2011) 137-141; DOI: 10.1016/j.ejmech.2010.10.024.
- 31. M. S. Alsaid, M. S. Bashandy and M. M. Ghorab, Novel quinolines bearing biologically active trimethoxyphenyl moiety as a new class of antitumor agents, Arzneimittel-Forschung Drug Res. 61 (2011) 527-531; DOI: 10.1055/s-0031-1296239.
- 32. M. S. Bashandy, M. S. Alsaid, S. I. Alqasoumi and M. M. Ghorab, Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivative carrying active sulfone moieties with potential anticancer activity, Arzneimittel-Forschung Drug Res. 61 (2011) 521-526; DOI: 10.1055/s-0031-1296238.
- 33. M. S. Alsaid, M. M. Ghorab, M. S. Al-Dosari and M. M. Hamed, Synthesis and in vitro anticancer evaluation of some novel hexahydroquinolinederivatives having a benzenesulfonamide moiety, Eur. J. Med. Chem. 46 (2011) 201-207; DOI: 10.1016/j.ejmech.2010.11.002.
- 34. F. Al-Omran, N. Al-Awadi, M. M. Abdel-Khalik, K. Kaul, A. A. El-Khair and M. H. Elnagdi,. 1-Substituted 3-dimethylaminoprop-2-en-1-ones as building blocks in heterocyclic synthesis: Routes to 6-aryl- and 6-heteroaryl-2H-pyran-2-ones and 6- and 4-arylpyridin-2(1H)-ones, J. Chem. Res. (S), 84 (1997) 84-85.
- 35. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. 82 (1990) 1107-1112; DOI: 10.1093/jnci/82.13.1107